IP Library › Granted Patent US 10,400,232
Granted Patent B2
US 10,400,232 · App. 15/026,093 · Granted Sep 3, 2019

Polymer engineered regenerating bioscavengers

Inventors: Alan J. Russell (Gibsonia, PA); Hironobu Murata (Pittsburgh, PA); Chad Cummings (Pittsburgh, PA); Richard R. Koepsel (Pittsburgh, PA)
Assignee: Carnegie Mellon University
C12N9/96A61K38/465A61K38/4826A61K47/58C12N9/16C12N9/6427C12Y301/01007C12Y304/21001
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,400,232
App. No.
15/026,093
Granted
Sep 3, 2019
Kind
B2
Abstract

Embodiments of the invention provide at least one polymer covalently conjugated to an esterase. The at least one polymer includes a plurality of oxime functional groups.

Claims (20)

1. A composition comprising:

at least one polymer covalently conjugated to an enzyme, the at least one polymer comprising a reactive functional group, wherein the reactive functional group reacts with an inhibitor attached to an active site of the enzyme.

2. The composition of claim 1 , wherein the enzyme comprises an esterase, and the reactive functional group comprises a plurality of oxime functional groups.

3. The composition of claim 2 , wherein the esterase is selected from the group consisting of acetylcholinesterase and butyrylcholinesterase.

4. The composition of claim 2 , wherein the esterase comprises chymotrypsin.

5. The composition of claim 2 , wherein the plurality of oxime functional groups comprises alkyne derivatives of 2-pyridine aldoxime.

6. The composition of claim 2 , wherein the plurality of oxime functional groups comprises an aldoxime.

7. The composition of claim 2 , wherein the plurality of oxime functional groups comprises a ketoxime.

8. The composition of claim 1 , wherein the reactive functional group reacts with the inhibitor attached to the active site of the enzyme, thus releasing the inhibitor from the active site and restoring activity to the active site of the enzyme.

9. The composition of claim 1 , wherein the at least one polymer comprises at least one environmentally responsive monomer.

10. The composition of claim 1 , wherein the at least one polymer is a copolymer comprising at least two different monomers, wherein at least one monomer is selected from the group consisting of aldoximes, ketoximes, muco-adhesion monomers, polyethylene glycol, bis-pyridinium oximes, N,N-dimethylacrylamide, N-isopropylacrylamide, (meth)acrylate, N,N-dimethylaminoethyl methacrylate, carboxyl acrylamide, 2-hydroxylethylmethacrylate, N-(2-hydroxypropyl)methacrylamide, quaternary ammonium monomers, sulfobetain methacrylate, oligo(ethylene glycol) methyl ether methacrylate, 2-PAM monomers, 4-PAM monomers, Clickable azide monomers, and combinations thereof.

11. A composition comprising:

a bioconjugate comprising:

an enzyme; and

at least one polymer covalently conjugated to the enzyme, wherein the at least one polymer comprises a plurality of reactive functional groups, and at least one reactive functional group of the plurality of reactive functional groups is positioned to react, in use, with a functional group on an inhibitor attached to an active site of the enzyme.

12. The composition of claim 11 , wherein the enzyme comprises an esterase, and the at least one reactive functional group comprises a plurality of oxime functional groups.

13. The composition of claim 12 , wherein the at least one reactive functional group comprises an oxime functional group positioned to exert a nucleophilic attack on a phosphoryl functional group of the inhibitor when the phosphoryl functional group is attached to the active site of the esterase, said nucleophilic attack resulting in removal of the phosphoryl functional group from the active site and restoration of activity to the esterase.

14. The composition of claim 12 , wherein the at least one polymer of the bioconjugate comprises a flexibility sufficient to react, in use, with a phosphoryl functional group of the inhibitor attached to the active site of the esterase.

15. The composition of claim 12 , wherein the at least one polymer covalently conjugated to the esterase forms a long lived covalent conjugate that is maintained in the body for a time period ranging from more than about one day to more than about one week.

16. The composition of claim 12 , wherein the at least one polymer is a co-polymer comprising at least two different monomers, wherein at least one monomer comprises a member selected from the group consisting of aldoximes, ketoximes, muco-adhesion monomers, polyethylene glycol, bis-pyridinium oximes, N,N-dimethylacrylamide, N-isopropylacrylamide, (meth)acrylate, N,N-dimethylaminoethyl methacrylate, carboxyl acrylamide, 2-hydroxylethylmethacrylate, N-(2-hydroxypropyl)methacrylamide, quaternary ammonium monomers, sulfobetain methacrylate, oligo(ethylene glycol) methyl ether methacrylate, 2-PAM monomers, 4-PAM monomers, Clickable azide monomers, and combinations thereof.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 25, 2020
From: RUSSELL, ALAN J.; MURATA, HIRONOBU; CUMMINGS, CHAD S.; KOEPSEL, RICHARD R
To: CARNEGIE MELLON UNIVERSITY
Reel/Frame 051916/0876 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 20, 2016
From: RUSSELL, ALAN J.; MURATA, HIRONOBU; CUMMINGS, CHAD; KOEPSEL, RICHARD R.
To: CARNEGIE MELLON UNIVERSITY
Reel/Frame 038331/0108 →
Continuity (2)
Provisional Application 61961097 · Oct 3, 2013
Related Publication 20160244741A1 · Aug 25, 2016